RAMPY NORTHRUP LLC for ILLUMINA, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Legislation and regulation affecting the genetic sequencing industry and the use of genetic information in research and clinical settings. H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017; implementation of Genetic Information Nondiscrimination Act of 2008 (P.L.110-233).
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN NORTHRUP | — |
| STACEY RAMPY | — |
Medicare/Medicaid MMM
Reimbursement of whole-genome sequencing clinical services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN NORTHRUP | — |
| STACEY RAMPY | — |
Budget/Appropriations BUD
H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; H.J.Res.123, Making further continuing appropriations for fiscal year 2018, and for other purposes (P.L.115-90); H.R.1370, Further Additional Continuing Appropriations Act, 2018 (P.L.115-96); National Institutes of Health (NIH) funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN NORTHRUP | — |
| STACEY RAMPY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.